WASHINGTON (PRWEB)
June 15, 2020

The Fibroid Foundation, a patient-founded nonprofit announces alliances with the LPGA Women’s Network, LPGA Amateur Golf Association and Springboard Enterprise’s Women’s Health Innovation Coalition. Sateria Venable, Founder of The Fibroid Foundation emphasized the significance of these alliances by saying, “Finding dynamic ways to elevate the conversation on women’s health is so important. The LPGA and Springboard are innovative organizations committed to women’s well-being.”

The LPGA Women’s Network and the LPGA Amateur Golf Association:

The LPGA Women’s Network and the LPGA Amateur Golf Association alliance elevates the conversation on women’s health and the need for self-care. The Fibroid Foundation chapters are aligning with the LPGA Women’s Network chapters across the U.S.

“I wanted to partner with the LPGA for many reasons,” said Fibroid Foundation Founder and CEO Sateria Venable. “First, of course, I love golf! It helps with spinal alignment, pelvic flexibility, and exercise—all very important for fibroid patients.”

The first part of the alliance began on April 28th as an informative webinar exclusive to the members of the LPGA Amateur Golf Association, outlining the benefits golf can provide for women’s health as well as providing information about fibroids, which affects the majority of women at some point in their lives. Vice President of LPGA Amateur Golf Association Mary-Lee Cobick stated, “We are proud to align with the Fibroid Foundation to support women’s health through education, informational services, and showing health benefits golf can provide.”

Continuing with the Fibroid Foundation’s efforts, the LPGA Women’s Network and LPGA Amateur Golf Association will provide advice and inspiration for new female golfers to highlight the health benefits of the game and in turn promote golf to members of the Fibroid Foundation through #inviteHER Experiences, LPGA Tournaments, and Women’s Leadership days hosted across the country.

Springboard Enterprises Women’s Health Innovation Coalition:

The Fibroid Foundation joins a coalition of innovative women’s health organizations collaborating to spur investment in women’s health innovation (https://www.womens.health/).

The coalition represents seven key sectors of women’s health – Autoimmune Diseases, Oncology, Bone Health, Gynecological Health, Reproductive Health, Heart Health, Cognitive and Brain Health. The Fibroid Foundation brings expertise in both gynecologic and reproductive health advocacy to this impressive collaborative effort.

Coalition members include: 2020 Mom, American Autoimmune Related Diseases Association, Inc.(AARDA), American Bone Health, Vermillion, Inc. / ASPiRA Laboratories, Avestria Ventures, BloomerTech, Davis Wright Tremaine LLC– Project W, Elidah, Elix, FEMselect, Femtech Collective, Femtech Focus, Femtech Insider, Future of Femtech, G2G Consulting, Gals bio Ltd, Gennev, Healthy Women, HLTH Foundation, Hormone Health Network, Life Whisperer, Madorra, Mahmee, Maven, Mymee, Pandia Health, Presagen, Pulse, Q2Q, RiskLD, Spark Solutions for Growth, SteelSky Ventures, The Fibroid Foundation, Univfy, VentriNova, Women of Wearables, and Women’s Health Innovation Summit.

Click here to Partner with The Fibroid Foundation!

About The Fibroid Foundation

The Fibroid Foundation is an organization founded by fibroid patient Sateria Venable in 2013. Our mission is to provide education, to advocate, to research, to legislate, and to provide product development consulting. We are 19 chapters strong and growing. Our readership is 26,000 women globally.

We are published in Obstetrics and Gynecology and Fertility and Sterility.

July is Fibroid Awareness Month. Our 2020 July focus is Health Equity.

One woman at a time, we are showing the world that we are empowered, and that we are driven to change our story!

Fibroid Statistics:

“Approximately 70% of women will have fibroids by the age of 50.

While not all women with fibroids have symptoms, the 30-50% who are symptomatic tend to

have multiple symptoms which can include abnormal uterine bleeding, pain, infertility, recurrent

pregnancy loss, urinary symptoms, and bloating. The prevalence and morbidity of these tumors

combined, result in fibroids being the leading cause of hysterectomy in the USA.” – Dr. Erica Marsh

Tags:

#FibroidFoundation

#SateriaVenable

#WomensHealth

#HealthEquity

#HealthDisparities

#LPGAWomensNetwork

#LPGAAmateurs

#LPGA

#Springboard

#UterineFibroids

#Fibroids

#PatientAdvocate

#Nonprofit

Share article on social media or email: